The key questions that need to be resolved are: (1) the expression pattern of CTA genes in EC; (2) the function of TTK in the development of EC and drug resistance; (3) the molecular mechanisms by which TTK promotes the development of cancer and chemoresistance; and (4) the discovery of effective TTK inhibitors for the treatment of EC. The gene discussed is TTK; the disease is cancer.